A-share subscription | Peptide raw material leader Viki Technology (920176.BJ) opens subscription, supplying Procter & Gamble and Unilever.

On July 13th, Weiqi Technology (920176.BJ) initiated its subscription, with an issue price of 22.16 yuan per share, a subscription limit of 397,300 shares, a P/E ratio of 14.99 times, listed on the North Exchange, with Guosen as its sponsor. The prospectus shows that Weiqi Technology is an innovative-driven cosmetics raw material specialist "small giant" enterprise, committed to promoting innovative raw materials and unique plant materials from China to the global market, creating a globally influential Chinese cosmetics raw material brand. The company has pioneered a peptide-based skincare system with "active peptides" as the core efficacy, offering over 10 peptide skincare solutions including anti-aging, anti-wrinkle, whitening, oil control and acne treatment, hair growth, soothing and anti-allergy, repair, moisturizing, eye care, lip care, and stretch mark repair. As of the signing date of this prospectus, the company has 22 cosmetics raw materials approved by the National Medical Products Administration, including 9 innovative raw materials. The number of approved new raw materials ranks at the forefront, with the number of innovative new raw materials approval ranking first. The company's designed and developed Erasin0003 is the first innovative raw material in China with independent intellectual property rights and approved by the National Medical Products Administration, and is one of the first two new raw materials included in the "Already-Used Raw Materials Catalog" after three years of safety monitoring. Inclusion in the "Already-Used Raw Materials Catalog" will reduce the application threshold for brands, reduce product approval costs, and shorten product approval timelines. Currently, the company is leveraging new raw materials to promote cooperation with international renowned brands such as Shiseido and Este Lauder, with some products already listed in the supply catalogs of these brands. Financially, the company expects to achieve operating revenues of approximately 165 million yuan, 248 million yuan, and 275 million yuan in the years 2023, 2024, and 2025, respectively. During the same period, net profits are expected to be approximately 42.2872 million yuan, 70.644 million yuan, and 90.8467 million yuan, respectively.